Site Therapeutics

Site Therapeutics is using high-throughput functional genomics to create fine-tuned control of immune cell function to treat a variety of immune-related conditions. Site Therapeutics is backed by The Column Group and is currently in stealth mode, so they have not publicly disclosed their research yet.

Jobs: